We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine STOCKHOLM, SWEDEN, October 21, 2024. Karolinska Development...
Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024 STOCKHOLM, SWEDEN – October 17...
Notice of Extraordinary General Meeting in Karolinska Development AB (publ) The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”...
Karolinska Development divests its holding in the Danish dermatology company Henlez STOCKHOLM, SWEDEN, September 23 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces the...
Karolinska Development’s portfolio company AnaCardio reports progress in two clinical trials with its drug candidate AC01 STOCKHOLM, SWEDEN September 17, 2024. Karolinska Development AB (Nasdaq...
Karolinska Developments portfolio company BOOST Pharma announces positive top-line results from a Phase 1/2 study with over 75% reduction of fracture rates in children with rare bone disease...
Karolinska Development’s portfolio company Biosergen announces successful treatment of first patient in a clinical trial of BSG005 STOCKHOLM, Sweden, August 30 2024. Karolinska Development AB...
Interim Report - January-June 2024 STOCKHOLM – 30 August 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-June 2024. The full report is...
Karolinska Development’s portfolio company PharmNovo receives EUR 17.5 million from the innovation program EIC Accelerator STOCKHOLM, SWEDEN – July 16, 2024. Karolinska Development AB (Nasdaq...
Karolinska Development’s portfolio company Umecrine Cognition secures funding for continued clinical development of golexanolone STOCKHOLM, SWEDEN – July 10, 2024. Karolinska Development AB...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
4 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
12 | 0 | 0 | 6.5 | 6.5 | 6.5 | 0 | 0 | DE |
26 | 0 | 0 | 6.5 | 6.5 | 6.5 | 285 | 6.5 | DE |
52 | 0 | 0 | 6.5 | 6.5 | 6.5 | 221 | 6.5 | DE |
156 | 0 | 0 | 6.5 | 6.5 | 6.5 | 705 | 6.5 | DE |
260 | 0 | 0 | 6.5 | 6.5 | 6.5 | 631 | 6.5 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions